RAPT Therapeutics Inc (RAPT)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current RAPT market cap is 41.95M. The company's latest EPS is USD -3.3411 and P/E is -0.36.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -33.92M | -33.22M | -32.52M | -29.33M | -19.79M |
| Net Income | -31.37M | -30.88M | -30.52M | -27.66M | -18.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 5.04M | 3.81M | 1.53M | 0 |
| Operating Income | -43.63M | -53.21M | -69.21M | -85.8M | -127.06M |
| Net Income | -43M | -52.89M | -69.2M | -83.84M | -116.8M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 199.72M | 173.33M | 155.82M | 127.18M | 108.47M |
| Total Liabilities | 26.92M | 26.29M | 24.98M | 17.96M | 12.96M |
| Total Equity | 172.8M | 147.04M | 130.84M | 109.22M | 95.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 84.6M | 118.97M | 198.64M | 266.21M | 173.33M |
| Total Liabilities | 11.48M | 14.79M | 12.26M | 21.04M | 26.29M |
| Total Equity | 73.12M | 104.18M | 186.38M | 245.17M | 147.04M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -69.29M | -97.05M | -27.08M | -55.24M | -72.86M |
| Investing | 83.49M | 104.13M | 15.89M | 35.1M | 53.55M |
| Financing | 989k | 1.45M | 9.04M | 9.74M | 9.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -35.47M | -40.49M | -61.03M | -70.77M | -97.05M |
| Investing | -843k | -87.44M | -81.35M | -45.49M | 104.13M |
| Financing | 49.9M | 75.46M | 141.48M | 131.18M | 1.45M |
| Market Cap | 41.95M |
| Price to Earnings Ratio | -0.36 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.88 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 34.96M |
| Average Volume (1 week) | 400.44k |
| Average Volume (1 Month) | 729.88k |
| 52 Week Change | -95.30% |
| 52 Week High | 26.28 |
| 52 Week Low | 0.78925 |
| Spread (Intraday) | 0.06 (5%) |
| Company Name | RAPT Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.rapt.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
